IκB kinase‐α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage‐based anticancer therapy

Abstract

AbstractActivation of the IκB kinase (IKK) complex has recurrently been linked to colorectal cancer (CRC) initiation and progression. However, identification of downstream effectors other than NF‐κB has remained elusive. Here, analysis of IKK‐dependent substrates in CRC cells after UV treatment revealed that phosphorylation of BRD4 by IKK‐α is required for its chromatin‐binding at target genes upon DNA damage. Moreover, IKK‐α induces the NF‐κB‐dependent transcription of the cytokine LIF, leading to STAT3 activation, association with BRD4 and recruitment to specific target genes. IKK‐α abrogation results in defective BRD4 and STAT3 functions and consequently irreparable DNA damage and apoptotic cell death upon different stimuli. Simultaneous inhibition of BRAF‐dependent IKK‐α activity, BRD4, and the JAK/STAT pathway enhanced the therapeutic potential of 5‐fluorouracil combined with irinotecan in CRC cells and is curative in a chemotherapy‐resistant xenograft model. Finally, coordinated expression of LIF and IKK‐α is a poor prognosis marker for CRC patients. Our data uncover a functional link between IKK‐α, BRD4, and JAK/STAT signaling with clinical relevance.